
ARIPLY 15 – Aripiprazole
For treatment of schizophrenia.
For treatment of moderate to severe manic states in bipolar disorder type 1
and for the prevention of new manic episodes in patients who predominantly
experienced manic episodes and who had previous manic episodes that responded
to aripiprazole treatment.
In addition, Ariply 5, 10, 15 are intended:
For combined treatment in major depressive disorder (MDD) for patients who
experienced a partial response to therapy.
For treatment of restlessness associated with an autistic disorder in children
(ages 6-17).